Metformin Sitagliptin — brands & medicines in Pakistan
Pakistan mein Metformin Sitagliptin ke 1 brands available hain. Drug class: Biguanide, DPP-4 Inhibitor. Neeche se koi bhi brand select karein aur uses, dosage, side effects aur price dekhein.
Quick Answer
Metformin Sitagliptin is a biguanide, dpp-4 inhibitor used in Pakistan for Type 2 diabetes mellitus (type 2 bukhar), Poor blood sugar control (bukhar ki kontrol kam ho), High fasting glucose levels (zor bukhar (high fasting glucose)). Available as 1 brand. Prescription required. Always confirm dose with a doctor or pharmacist.
What is Metformin Sitagliptin?
Metformin Sitagliptin is a biguanide, dpp-4 inhibitor used in Pakistan for a range of medical conditions. Doctors and pharmacists in Pakistan recognize Metformin Sitagliptin under multiple brand names — currently 1 listed on PakVita (1 tablet). The information below is a synthesis from DRAP-registered medicine entries, BNF, and WHO Essential Medicines references.
Common indications
- Type 2 diabetes mellitus (type 2 bukhar)
- Poor blood sugar control (bukhar ki kontrol kam ho)
- High fasting glucose levels (zor bukhar (high fasting glucose))
- High post-meal blood sugar (baad-e-khana zyada bukhar)
- Prevention of diabetes complications
- High blood pressure (BP high hona)
Indication and dose vary by medical condition, age, weight, and other factors. Always confirm with a qualified doctor or pharmacist before starting.
Typical dosage
As prescribed
This is a general adult guidance pattern based on the manufacturer's label for one of the Metformin Sitagliptin brands listed below. Children, elderly patients, pregnant women, and people with kidney or liver impairment usually need different dosing — confirm with your doctor.
Side effects
Common (usually mild)
- Nausea
- Diarrhoea
- Abdominal discomfort
Serious — stop and see a doctor
- Severe allergic reactions
- Low blood sugar levels
- Unusual bleeding or bruising
Important warnings
- Avoid using Sita-Met Tablet if you have type 1 diabetes.
- Do not use in diabetic ketoacidosis cases.
- Patients with severe kidney disease should avoid it.
Drug class
Diabetes MedicinesMetformin Sitagliptin brands in Pakistan (1)
Click any brand to see full uses, dosage, side effects, prices, and warnings.
Frequently asked questions
What is Metformin Sitagliptin used for in Pakistan?
Metformin Sitagliptin is commonly used for Type 2 diabetes mellitus (type 2 bukhar), Poor blood sugar control (bukhar ki kontrol kam ho), High fasting glucose levels (zor bukhar (high fasting glucose)), High post-meal blood sugar (baad-e-khana zyada bukhar), and other indications. It belongs to the biguanide, dpp-4 inhibitor drug class.
What is the typical dosage of Metformin Sitagliptin?
Typical adult dosing is described by manufacturers as: "As prescribed". Always confirm dose, duration, and timing with a qualified doctor or pharmacist — dose depends on indication, weight, age, kidney/liver function, and other medications.
What are the common side effects of Metformin Sitagliptin?
Common side effects include Nausea, Diarrhoea, Abdominal discomfort. Most are mild and resolve as the body adjusts. Stop the medicine and contact a doctor if side effects are severe, persistent, or include allergic symptoms (rash, swelling, breathing difficulty).
When should I stop Metformin Sitagliptin and see a doctor?
Stop Metformin Sitagliptin and seek urgent medical care if you experience: Severe allergic reactions; Low blood sugar levels; Unusual bleeding or bruising. These are serious signs that need immediate attention.
Is Metformin Sitagliptin available without a prescription in Pakistan?
Prescription required.
What brands of Metformin Sitagliptin are available in Pakistan?
1 brand of Metformin Sitagliptin is listed on PakVita: 1 tablet. Browse the brand list below and click any name for prices, dosage, and full information.
Sources
- DRAP Registered Drug Products Database — Drug Regulatory Authority of Pakistan
- British National Formulary (BNF) — BMJ Group & Pharmaceutical Press
- WHO Model List of Essential Medicines, 23rd ed. — World Health Organization